UK MHRA Guidance directory

All uk mhra guidance435 total

• Clinical trials for medicines: roles and responsibilities2026-07-07
• MHRA Innovation Office2026-07-06
• Clinical investigations for medical devices2026-07-06
• Clinical trials for medicines: ending a clinical trial2026-07-06
• Submit changes to labels and Patient Information Leaflets as a self-certification2026-07-03
• Medicines eligible for Northern Ireland MHRA Authorised Route2026-07-02
• Medicines: apply for a variation to your marketing authorisation2026-07-02
• Medicines that you cannot export from the UK or hoard2026-07-02
• Borderline products: how to tell if your product is a medicine2026-07-02
• MHRA Innovation Office: guidance and support2026-07-01
• Medicines: packaging, labelling and patient information leaflets2026-07-01
• MHRA Innovation Accelerator 2026-06-29
• Innovation Accelerator2026-06-29
• Borderline products: medical devices and other products2026-06-29
• Register medical devices to place on the market2026-06-26
• Register of authorised online sellers of medicines in Northern Ireland2026-06-24
• Advice for consumers2026-06-18
• Project Orbis2026-06-17
• Antimicrobial resistance awareness: toolkit for healthcare providers2026-06-16
• Medical devices: ask for a regulatory advice meeting from the MHRA2026-06-11
• Value based procurement for medical technology2026-06-11
• Contact the MHRA2026-06-11
• Regulation of medical devices in Northern Ireland2026-06-11
• Opportunities for patients and the public to be involved in the work of the MHRA2026-06-10
• AI Airlock Sandbox Phase 2 Programme Report2026-06-09
• AI Airlock Simulation Workshops2026-06-09
• National AI Commission: Ask Me Anything2026-06-09
• Find product information about medicines2026-06-08
• Clinical trials for medicines: modifying a clinical trial approval2026-06-08
• Community Pharmacy Contractual Framework: financial year 2026 to 20272026-05-29
• Innovative Licensing and Access Pathway (ILAP)2026-05-19
• International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines2026-05-19
• Medicines Pipeline data2026-05-13
• Medical devices: conformity assessment and the UKCA mark2026-05-13
• RSV Vaccine Factsheet – Information for Patients, Parents and Carers2026-05-07
• Export drugs and medicines: special rules2026-05-06
• The Innovative Devices Access Pathway (IDAP)2026-04-30
• Good laboratory practice (GLP) for safety tests on chemicals2026-04-29
• Clinical trials for medicines: Clinical Trials Regulations transitional arrangements2026-04-27
• Clinical trials for medicines: Compliance with ICH E6 good clinical practice (GCP) in the United Kingdom2026-04-27
• Clinical trials for medicines: Diagnostic Radiopharmaceutical Investigation Medicinal Products and Good Manufacturing Practice requirements2026-04-27
• Clinical trials for medicines: collection, verification and reporting of safety events2026-04-27
• Formulating responses to GCP inspection findings2026-04-27
• Clinical trials for medicines: apply for approval in the UK2026-04-27
• Clinical trials for medicines: expert advice2026-04-27
• Clinical trials for medicines: guidance on quality and risk proportionality2026-04-27
• Clinical trials for medicines: Notification of Serious Breaches of GCP or the trial protocol2026-04-27
• Clinical trials for medicines: Declaration of Helsinki and Clinical Trial Regulations alignment2026-04-27
• Clinical trials for medicines: Good clinical practice inspections2026-04-27
• Clinical trials for medicines: International Council for Harmonisation (ICH) annotations2026-04-27
• Clinical trials for medicines: labelling2026-04-27
• Clinical trials for medicines: notifiable trials2026-04-27
• Clinical Trials Regulations enforcement provisions2026-04-27
• Clinical trials for medicines: non-investigational medicinal products2026-04-27
• Clinical trials for medicines: Archiving and retention of clinical trial records2026-04-27
• Clinical trials for medicines: good manufacturing practice and radiopharmaceutical investigational medicinal products2026-04-27
• MHRA fees2026-04-21
• UK Clinical Research Delivery key performance indicators: methodology2026-04-15
• Medicines: Get integrated scientific advice from the MHRA and NICE2026-04-14
• Antimicrobial resistance (AMR) in VDEC2026-04-09
• Get medicines to NHS patients earlier via the MHRA-NICE aligned pathway2026-04-09
• National assessment procedure for medicines2026-04-09
• Medicine supply management2026-04-07
• Apply for a licence to market a medicine in the UK2026-04-01
• Approving clinical investigations2026-03-31
• Clinical trials for medicines: apply for authorisation in the UK2026-03-31
• Clinical investigations: compiling a submission2026-03-31
• Clinical investigations in Great Britain2026-03-31
• Clinical investigations in Northern Ireland2026-03-31
• Medical devices that need a clinical investigation2026-03-30
• Clinical investigations: statistical considerations2026-03-30
• Clinical investigations: biological safety assessments2026-03-30
• Clinical investigations for electrically powered devices2026-03-30
• Use of dual energy x-ray absorptiometry (DEXA) scans: government position2026-03-30
• Clinical investigations: investigators' responsibilities2026-03-30
• MHRA approach to medicines using non-animal methods2026-03-25
• Clinical Trials Regulations webinar recordings2026-03-25
• Meningitis – Patient Factsheet2026-03-20
• Submitting an application for review by the ACBS2026-03-20
• Improving Patient Information2026-03-18
• Get more help to apply for medicines Integrated Scientific Advice (ISA)2026-03-16
• Access Generic Medicines Work Sharing Initiative2026-03-12
• Implementation of medical devices future regime2026-03-12
• Clinical trials that include an in vitro diagnostic device2026-03-09
• Clinical trials for medicines: MHRA phase I accreditation scheme2026-03-06
• Medicines: get scientific advice from the MHRA2026-03-04
• Paclitaxel drug-coated balloons and drug-eluting stents2026-03-03
• MHRA Portal: register to submit forms2026-03-02
• Category lists following implementation of the Windsor Framework2026-03-02
• Early Access to Medicines Scheme: Overview2026-03-02
• Medicines: reclassify your product2026-02-27
• Strengthening supply chain cyber security at the MHRA2026-02-26
• Medicines: Marketing Authorisation Holders' submission of Nitrosamine risk evaluation, risk assessment and confirmatory testing2026-02-25
• Isotretinoin: an expert review of suspected psychiatric and sexual side effects2026-02-25
• Regulating medical devices in the UK2026-02-20
• Timelines for acceptance of CE marked medical devices in Great Britain (GB)2026-02-16
• A guide to defective medicinal products2026-02-16
• Blood: authorisations and safety reporting2026-02-13
• MoD integration into the NHS Prescription Service: directions2026-02-11
• Pharmacovigilance following agreement of the Windsor Framework2026-02-09